Embryo development and transfer are central components of modern reproductive medicine. Traditionally, embryos were transferred on day 2 or 3 after egg retrieval, at the early cleavage stage (2–8 cells).
Today, extended embryo culture to the blastocyst stage (day 5–6) has become an important advancement in IVF. Transferring embryos at this more advanced developmental stage allows for improved selection of viable embryos and better synchronization with the uterine environment.
The blastocyst represents an advanced stage of embryo development, typically reached around day 5 after fertilization. At this stage, the embryo has differentiated into distinct structures, including a fluid-filled cavity (blastocoel), an inner cell mass—which will develop into the fetus—and an outer cell layer (trophectoderm), which forms the placenta.
This level of development provides important information about embryo viability and is a key factor in modern embryo selection for transfer.
Our approach is designed to closely mimic the natural process of embryo development. With blastocyst transfer, the embryo is placed into the uterus at the stage when implantation would naturally occur.
In a natural conception, the embryo reaches the uterus as a blastocyst and begins the implantation process shortly thereafter. By aligning embryo transfer with this physiological timing, we aim to optimize synchronization between the embryo and the endometrium.
Transferring embryos at the blastocyst stage offers several important advantages:
Natural Synchronization:
Transfer on day 5–6 aligns closely with the natural timing of embryo implantation, improving synchronization between the embryo and the endometrium.
Improved Embryo Selection:
Extended culture allows identification of embryos with the highest developmental potential, supporting more accurate selection for transfer.
Reduced Risk of Multiple Pregnancy:
By selecting high-quality embryos, it is often possible to transfer a single embryo, thereby reducing the risk of multiple pregnancy while maintaining high success rates.
Whether blastocyst transfer is the most appropriate option for you is determined individually, based on your medical history, ovarian response, and embryo development.
Our team carefully evaluates all relevant clinical factors to recommend the most suitable strategy for your treatment. The goal is to optimize both safety and success while ensuring a personalized approach tailored to your specific situation.
We aim to provide the best options and the latest technologies to facilitate your journey towards your desired pregnancy. Dr. Roukoudis and his team will guide you individually and per the latest medical research.